scispace - formally typeset
Search or ask a question

Showing papers by "Rhône-Poulenc published in 1986"


Journal ArticleDOI
TL;DR: The drug incorporation efficiency was markedly improved after saturation of the dispersing phase with cisplatin, and the amount of drug incorporated increased with increasing mean microsphere diameter.

140 citations


Patent
19 Dec 1986
TL;DR: In this article, a method for the control of arthropod, plant nematode or helminth pests using compounds of formula (I), wherein Y is halogen, cyano, nitro, rSO2, RSO or RS in which R is alkyl, cycloalkyl or alkenyl, thiocyanato, sulphamoyl, carbamoyls, alkoxycarbonyl, alkanoyl or alkym; Z represents hydrogen, an amino group -NR1R2, alkylsulphenylam
Abstract: A method for the control of arthropod, plant nematode or helminth pests using compounds of formula (I), wherein Y is halogen, cyano, nitro, RSO2, RSO or RS in which R is alkyl, cycloalkyl or alkenyl, thiocyanato, sulphamoyl, carbamoyl, alkoxycarbonyl, alkanoyl or alkyl; Z represents hydrogen, an amino group -NR1R2, alkylsulphenylamino, alkoxymethyleneamino, halogen, alkyl, carboxy, alkylthio, alkylsulphinyl or alkylsulphonyl, trialkylsilylmethyl, trialkylsilyl, cyano or nitro; R3 represents halogen, alkyl or alkoxy, halogen-substituted alkylthio or alkylsulphinyl, nitro, cyano, or alkylsulphonyl; and R4 represents halogen, cyano, nitro, alkyl or cycloalkyl, and n is 1 to 5, and salts thereof, provided that R4, Y and Z do not simultaneously represent one of nitro, cyano, halogen and unsubstituted alkyl; persticidal compositions, novel compounds and processes for their preparation are described.

136 citations


Journal ArticleDOI
01 Jun 1986-Polymer
TL;DR: In this article, the degree of crystallinity of poly(ethylene terephthalate glycol) (PET) obtained by induced crystallization during stretching of amorphous PET films is related to the amorphus orientation of the samples.

75 citations


Patent
30 Jan 1986
TL;DR: In this paper, the authors describe a catalytic process for producing ethanol and/or ethyl acetate in relatively moderate temperature and pressure conditions, with a view to producing ethanol or acetate.
Abstract: Acetic acid is hydrogenated in vapour phase to produce ethanol in free form or in the combined form of ethyl acetate. The catalytic process now found takes place in relatively moderate temperature and pressure conditions, with a view to producing ethanol and/or ethyl acetate, and is characterised in that the catalyst consists of ruthenium deposited on a silica support. A process for manufacturing the catalyst is also claimed.

74 citations


Journal ArticleDOI
TL;DR: In this article, a novel approach is introduced for the systematic development of approximate reaction networks that are the basis of the reactor model and applied to a complex kinetic network containing 20 parameters which is accurately approximated by two simple tendency models.

68 citations


Journal ArticleDOI
01 Jan 1986-Lipids
TL;DR: The potent inhibitors described are powerful tools to control in vivo the sterol profile of plant cells and therefore to study the structural and functional roles of sterols in cell membranes and could be of value in plant protection.
Abstract: Several enzymes of plant sterol biosynthesis involve during their catalysis postulated or demonstrated carbocationic high energy intermediates (HEI). The aim of this study was to interfere with plant sterol biosynthesis by means of rationally designed species able to mimic these carbocationic HEI. It has been demonstrated previously that the design of transition state (TS) or HEI analogues could lead to powerful and specific inhibitors of enzymes. We applied this approach to the following target enzymes: 2,3-epoxy-2,3-dihydroqualene cyclase, AdoMet-cycloartenol-C-24-methyltransferase (AdoMet CMT), cycloeucalenol-obtusifoliol isomerase (COI) and Δ8-Δ7-sterol isomerase. Very potent inhibitors have been obtained in the four cases. As an example, analogues of cycloartenol substituted at C-25 by a charged heteroatom (N, As, S) have been synthesized and shown to be able to mimic the C-25 carbocationic HEI involved in the reaction catalyzed by the AdoMet CMT. These compounds were shown to be very potent and specific inhibitors of this enzyme both in vitro (Ki=2.10−8 M, Ki/Km=10−3) and in vivo. The potent inhibitors described are powerful tools to control in vivo the sterol profile of plant cells and therefore to study the structural and functional roles of sterols in cell membranes. Moreover, these compounds constitute leader molecules of a new class of rationally designed inhibitors which could be of value in plant protection.

67 citations


Journal ArticleDOI
01 May 1986

67 citations


Journal ArticleDOI
TL;DR: Results show that concentrations of pefloxacin in excess of the minimum inhibitory concentrations for many important pathogens can be rapidly achieved in plasma and urine with the 400 mg bid regimen with both iv and oral routes.
Abstract: Multiple-dose kinetics of pefloxacin was determined in 12 normal male subjects given 400 mg pefloxacin by iv 1 h-infusion every 12 h for 16 doses. Twelve other subjects (6 men and 6 women) were given 400 mg pefloxacin by mouth every 12 h for 18 doses. Plasma and urine concentrations of pefloxacin and its main metabolites (N-desmethyl pefloxacin or norfloxacin and pefloxacin N-oxide) were measured by high performance liquid chromatography. The bioavailability of pefloxacin was complete and plasma concentrations after iv or oral administration were similar. Pefloxacin was rapidly absorbed from the gastrointestinal tract and reached maximum plasma concentrations about 1 h after dosing. Pefloxacin elimination (T 1/2 beta) increased from 11.00 +/- 2.64 h after the first iv dose to 13.93 +/- 3.58 h after the last iv dose (P less than 0.01). Apparent total body clearance decreased from 148.5 +/- 47.6 to 106.9 +/- 39.2 ml/min (P less than 0.01) because of decreased non-renal clearance (apparent volume of distribution did not significantly change over the repeated pefloxacin administration). Similar results were obtained after repeated oral dosing. Renal clearance of pefloxacin was low (7.47 +/- 2.28 ml/min) indicating that non-renal clearance represents the major route of elimination of this quinolone. Urinary excretion of pefloxacin and N-desmethyl and N-oxide metabolites was approximately 31% of the pefloxacin dose and beta-elimination half-lives of these metabolites were very close to that of pefloxacin (13.34 +/- 2.72 h and 11.95 +/- 2.64 h respectively). Due to a possible saturable process in the metabolic pathway, some accumulation occurred during repeated iv or oral treatment (accumulation ratio = 1.37 +/- 0.20). These results show that concentrations of pefloxacin in excess of the minimum inhibitory concentrations for many important pathogens can be rapidly achieved in plasma and urine with the 400 mg bid regimen with both iv and oral routes.

64 citations


Journal ArticleDOI
TL;DR: In vitro results suggest the existence of two types of regulation of the D1 receptor by CCK8 depending on the identity (mixed or not mixed) of their innervating fibres.

52 citations


Patent
21 Jul 1986
TL;DR: A glass polishing composition is composed of suspension of particulate ceric oxide and at least one colorless oxide of a lanthanide or yttrium rare earth, preferably an oxide of lanthanum, samarium, europium, gadolinium, dysprosium, thulium, ytterbium, lutecium, or mixtures thereof as mentioned in this paper.
Abstract: Glass polishing compositions, advantageously recycled into glassmaking formulations, are comprised of suspension of particulate ceric oxide and at least one colorless oxide of a lanthanide or yttrium rare earth, preferably an oxide of lanthanum, samarium, europium, gadolinium, dysprosium, thulium, ytterbium, lutecium, yttrium, or mixtures thereof.

49 citations


Patent
09 May 1986
TL;DR: In this paper, a composition for the preparation by extrusion of microparticles permitting a prolonged release of a biologically active substance, which composition consists of a bioactive substance, one or more non-hydrophilic polymers and from 10 to 40% by weight either of a mixture of at least two lipid excipients one of which has the property of dissolving or gelling the polymer or polymers, and the other has lubricating properties or of a lipid excipient having both the property and liveness properties.
Abstract: 1. A composition for the preparation by extrusion of microparticles permitting a prolonged release of a biologically active substance, which composition consists of a biologically active substance, one or more non-hydrophilic polymers and from 10 to 40% by weight either of a mixture of at least two lipid excipients one of which has the property of dissolving or gelling the polymer or polymers and the other has lubricating properties or of a lipid excipient having both the property of dissolving or gelling the polymer or polymers and lubricating properties, and, if appropriate, one or more additives chosen from diluents and antistatic agents.

Patent
Maestro Patrick1
28 Apr 1986
TL;DR: In this article, the formula Ln2S3 corresponds to a rare earth element from the group formed by lanthanides and yttrium in thermoplastic or thermosetting plastics materials, special polymers, in resins used as a component of paints and glazes, in nail varnishes and make-up materials used in cosmetology.
Abstract: 1. Use as coloured pigments of at least one sulphide of rare earths corresponding to the formula Ln2 S3 in which Ln represents at least one element from the group formed by lanthanides and yttrium in thermoplastic or thermosetting plastics materials, special polymers, in resins used as a component of paints and glazes, in nail varnishes and make-up materials used in cosmetology.

Patent
11 Jun 1986
TL;DR: A compound of cerium IV corresponding to the following general formula (I : Ce (M)x (OH)y (NO3 )z wherein - M represents an alkali metal or a quaternary ammonium radical, - y is such that y = 4 - z + x and - z is between 0.4 and 0.7.
Abstract: 1. A compound of cerium IV corresponding to the following general formula (I) : Ce (M)x (OH)y (NO3 )z wherein : - M represents an alkali metal or a quaternary ammonium radical, - x is between 0.01 and 0.2, - y is such that y = 4 - z + x and - z is between 0.4 and 0.7.

Patent
28 Mar 1986
TL;DR: In this article, a block copolyetheramides with melting point of at least 150°C, a glass transition temperature not exceeding -5°C and a melt viscosity of at at least 100 poises, are prepared by prepolymerizing a mixture of a salt of a short-chain aliphatic dicarboxylic acid and a short chain aliphastic diamine with a fatty acid(s) dimer or amino derivative thereof, and then polycondensing the prepolymers in the presence of a strong organic or inorganic oxyacid
Abstract: Novel, homogeneous and flexible block copolyetheramides, having a melting point of at least 150° C., a glass transition temperature not exceeding -5° C. and a melt viscosity of at least 100 poises, are preferably prepared by prepolymerizing a mixture of a salt of a short-chain aliphatic dicarboxylic acid and a short-chain aliphatic diamine with a fatty acid(s) dimer or amino derivative thereof, and then polycondensing the prepolymer in the presence of a strong organic or inorganic oxyacid, with a polyoxyalkylenediamine or a polyoxyalkylenedicarboxylic acid having a number-average molecular weight ranging from 300 to 1200.

Patent
13 Feb 1986
TL;DR: Gel-forming aqueous microemulsions as discussed by the authors are used for reversible stabilization or plugging of soil/rock formations, e.g., underground well formations, which are comprised of an aqueously solution of a water-soluble alkali metal silicate, a gelling reagent therefor, and at least one surface active agent.
Abstract: Stable, gel-forming aqueous microemulsions, well adopted for the reversible stabilization or plugging of soil/rock formations, e.g., subterranean well formations, are comprised of (i) an aqueous solution of a water-soluble alkali metal silicate, (ii) a gelling reagent therefor, and (iii) at least one surface active agent.

Patent
27 Jun 1986
TL;DR: In this article, the specific surface of a ceric oxide-based composition was stabilised at high temperature, which allowed it to be used in the field of catalysis, and its preparation and its applications were discussed.
Abstract: The invention permits the specific surface of a ceric oxide-based composition to be stabilised at high temperature. … The invention also relates to its preparation and its applications especially in the field of catalysis.

Journal ArticleDOI
TL;DR: The specific binding of [3H]PK 11195 to the peripheral-type benzodiazepine binding site is inhibited by the l-enantiomer of N,N-diethyl-alpha-methyl-2-phenyl-4-quinolinepropanamide but not by its d-enantomer, while the same stereoselectivity was found for the displacement of the binding in vivo.

Journal ArticleDOI
J. Dow1, J. Chazal, A. Frydman1, P. Janny, R. Woehrle1, F. Djebbar1, J. Gaillot1 
TL;DR: Cerebro-spinal fluid (CSF) quickly attains therapeutic levels of pefloxacin with the present dosage regimen, and the apparent half-life (T1/2) of transfer of pe FLXacin from plasma to CSF was 1.26 +/- 0.18 h, which is similar to the elimination T2/2 found previously in plasma, thus accumulation of peFLoxacIn in CSF is unlikely.
Abstract: Nine subjects (5 women) aged between 17-66 years, with hydrocephalus were studied. An external ventricular drain was introduced for diagnostic purposes. Cerebro-spinal fluid (CSF) and plasma samples were obtained at suitable intervals after 1 h infusion of 400 mg pefloxacin. In plasma, pefloxacin Cmax was 8.54 +/- 1.53 (mean +/- S.E.M.) mg/l, at the end of infusion, whereas N-desmethyl pefloxacin concentration was 0.17 +/- 0.03 mg/l. The metabolite accounted for only 2% of plasma levels of pefloxacin. In CSF, pefloxacin Cmax was 2.97 +/- 0.32 mg/l, 5-6 h after the start of infusion, whereas N-desmethyl pefloxacin Cmax varied between 0.1-0.2 mg/l. Apart from the 1 h sample, the CSF/plasma ratio of pefloxacin was 60% which is similar to the unbound fraction of pefloxacin in plasma. The apparent half-life (T1/2) of transfer of pefloxacin from plasma to CSF was 1.26 +/- 0.18 h, assuming a first order process, while the apparent elimination T1/2 in CSF was 13.40 +/- 1.76 h, which is similar to the elimination T1/2 found previously in plasma, thus accumulation of pefloxacin in CSF is unlikely. With the present dosage regimen, CSF quickly attains therapeutic levels of pefloxacin.

Patent
28 Mar 1986
TL;DR: In this article, the authors proposed a crosslinkable polysilazane composition comprising at least one polysilaxane containing at least 2, preferably at least 3,.tbd.
Abstract: A crosslinkable composition comprising at least one polysilazane containing at least 2, preferably at least 3, .tbd.SiH groups per molecule and at least 2 SiR 2 groups per molecule, R 2 being an unsaturated hydrocarbon radical and a catalytically effective quantity of a metal element or of a metal compound to catalyze the hydrosilylation reaction SiH/SiR 2 . The compositions according to the invention can crosslink under the effect of heat and can be used for coating or impregnating substrates with ceramic material after pyrolysis. The mechanical properties of the crosslinked compositions are assessed by evaluating the relative rigidity RR measured by the fiber torsion pendulum method (FIG. 1).

Patent
15 Jan 1986
TL;DR: Aqueous nitric solutions of salts of at least one rare earth, and containing contaminating amounts of one alkaline earth cation, e.g., barium and radium, are conveniently purified by liquid/liquid extracting same with an organic phase which comprises a polyether extractant for said at least 1 rare earth and whereby said 1 earth ion is selectively transferred into said organic phase.
Abstract: Aqueous nitric solutions of salts of at least one rare earth, and containing contaminating amounts of at least one alkaline earth cation, e.g., calcium, barium and/or radium, are conveniently purified by liquid/liquid extracting same with an organic phase which comprises a polyether extractant for said at least one alkaline earth cation, e.g., a crown ether, and whereby said at least one alkaline earth cation is selectively transferred into said organic phase.

Patent
06 May 1986
TL;DR: In this paper, surface active, storage-stable compositons for the formulation of a variety of active agents, e.g., biocides, and the conversion thereof into stable, hmogenous liquid suspensions, are comprised of at least one first polyolefinic copolymeric surface-active agent and at least second mixed sulfate and/or phosphate ester surface active agent.
Abstract: Novel surface-active, storage-stable compositons well adopted for the formulation of a variety of active agents, e.g., biocides, and the conversion thereof into stable, hmogenous liquid suspensions, are comprised of at least one first polyolefinic copolymeric surface-active agent (a) and at least one second mixed sulfate and/or phosphate ester surface-active agent (b).

Patent
06 May 1986
TL;DR: In this paper, an organopolysilazane composition that can be crosslinked by an energy input is presented, where the energy input capable of generating the radical may be provided in the form of heat, ultraviolet radiation, an electron beam, and the like.
Abstract: An organopolysilazane composition that can be crosslinked by an energy input. The organopolysilazane composition comprises an organopolysilazane and a free radical generator in an amount effective to crosslink the organopolysilazane. The energy input capable of generating the radical may be provided in the form of heat, ultraviolet radiation, an electron beam, and the like. The crosslinked organopolysilazane compositions exhibit good thermal behavior and, in particular, can be used, after pyrolysis, as precursors of ceramic products.

Patent
09 Jun 1986
TL;DR: In this paper, a masterbatch for delustring processable polyamides is described, which contains 50 to 90% of a copolyamide used as a binder and consisting of 30 to 100% of hexamethylene adipamide units and 0-70% of caproamide units.
Abstract: The present invention relates to masterbatches for delustring processable polyamides. They contain 50 to 90% of a copolyamide used as a binder and consisting of 30 to 100% of hexamethylene adipamide units and 0-70% of caproamide units and 10 to 50% by weight of anatase titanium dioxide coated with 0.01 to 1.5% of silica and 1 to 3% of alumina and treated with a polydimethylsiloxane oil present in a proportion of 0.2 to 10% by weight of TiO 2 . They are obtained by adding TiO 2 powder into the autoclave immediately after the pressure release stage, when the reaction mass is still at a high temperature and before vacuum is applied. The masterbatches according to the invention may be introduced directly into the liquid stream of the polymer to be spun.

Journal ArticleDOI
TL;DR: In this paper, the preparation of cerie isopropoxide from ceric ammonium nitrate in dimethoxyethane (DME) and IPA was described in detail.
Abstract: The preparation of cerie isopropoxide from ceric ammonium nitrate in dimethoxyethane (DME) and isopropanol (IPA) is described in detail. Quantitative yield is obtained when sodium isopropoxide is used as a base. When ammonia, instead of sodium isopropoxide, is used the reaction has difficulty going to completion because of an apparent equilibrium. We show that NH4NO3 reacts with pure cerium isopropoxide in DME liberating NH3 and IPA.

Patent
25 Nov 1986
TL;DR: In this article, the aminolysate obtained during the first stage is reacted with at least one organosilicon compound chosen from an organochlorosilane, an organocorligo-disilylsilazane, a polysilazane containing at least three chlorine atoms per molecule in the presence of a tertiary amine.
Abstract: In a first stage, the aminolysis of a dichlorosilane and/or of a dichlorodisilane is carried out and the amine chloride formed is removed and, in a second stage, the aminolysate obtained during the first stage is reacted with at least one organosilicon compound chosen from an organochlorosilane, an organochlorodisilane, an organochloropolysilazane and an organochloropolydisilylsilazane containing at least three chlorine atoms per molecule, in the presence of a tertiary amine. A cationic polymerisation may be advantageously optionally carried out on the aminolysate obtained in the first stage. The polysilazanes thus treated exhibit a high heat resistance and can be employed especially as precursors of ceramic products, with a high yield of mineral product.

Journal ArticleDOI
TL;DR: In this paper, the reaction of a hydroxylated base with 3-chloro-2-methyl-6-methylene 1,7-octadiene in the presence of a palladium complex and a quaternary ammonium salt gives a new C 10 terpene synthon.

Patent
03 Mar 1986
TL;DR: In this paper, a fine powder of stabilized zirconia is obtained and a process for its preparation and application of the powder in ceramic compositions to obtain good mechanical, thermomechanical and electrical properties is described.
Abstract: A fine powder of stabilized zirconia a process for its preparation and application of the powder in ceramic compositions to obtain good mechanical, thermomechanical and electrical properties. A zirconia hydrate sol having a pH between 0.5 and 5 and containing elementary acicular crystals having dimensions of from about 10 to 500 Å which are agglomerated into submicron aggregates of from abuot 100 to 5000 Å in diameter is mixed with a solution of a stabilizing agent, preferably yttrium; the suspension is dried; the dried suspension is calcined at a temperature of from about 700° C. to 1,300° C. for preferably from about 30 minutes to 24 hours; and if needed, the powder obtained is milled.

Patent
03 Jul 1986
TL;DR: A ceric oxide composition, the specific surface of which remains essentially stable at elevated temperatures and which is thus well adopted for purposes of catalysis, is comprised of a plurality of solid, porous, finely divided ceric dioxide particulates, said particulates advantageously having an effective amount of at least one oxide of another metallic element A intimately dispersed therein as to essentially prevent the coalescence of the micropores thereof as mentioned in this paper.
Abstract: A ceric oxide composition, the specific surface of which remains essentially stable at elevated temperatures and which is thus well adopted for purposes of catalysis, is comprised of a plurality of solid, porous, finely divided ceric oxide particulates, said ceric oxide particulates advantageously having an effective amount of at least one oxide of another metallic element A intimately dispersed therein as to essentially prevent the coalescence of the micropores thereof.

Journal ArticleDOI
01 Jun 1986-Polymer
TL;DR: In this article, the authors proposed a two-parameter model to describe the sorption of siloxane chains onto silica particles immersed in the polymeric liquid at room temperature.

Patent
Guy Cyprien1
05 Mar 1986
TL;DR: In this paper, hair is removed from selected skin area by applying a coating of a curable organopolysiloxane composition thereon, permitting the organopoly-siloxanes composition to crosslink into a silicone elastomer, e.g., in the form of a solid layer or foam, and embedding unwanted hair therein, and then stripping the injected hair from said skin area, whereby the skin area is essentially depilated.
Abstract: Unwanted hair is removed from selected skin area by applying a coating of a curable organopolysiloxane composition thereon, permitting the organopolysiloxane composition to crosslink into a silicone elastomer, e.g., in the form of a solid layer or foam, and embed unwanted hair therein, and then stripping the silicone elastomer and embedded hair from said skin area, whereby said skin area is essentially depilated.